{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:11:24Z","timestamp":1792501884553,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The pathophysiology of immune thrombocytopenia (ITP) involves immune-mediated platelet destruction. The presence of adipose tissue in obese individuals creates an inflammatory environment that could potentially impact the clinical course and outcomes of ITP. However the relationship between obesity and ITP outcomes has not been well described. We evaluated ITP outcomes in 275 patients diagnosed with primary ITP from 2012 to 2022. Patients were categorized into four groups based on their body mass index (BMI) at diagnosis. Female gender was associated with a lower platelet count at the time of diagnosis at any BMI. Patients with high BMI had lower platelet counts at diagnosis and at platelet nadir (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), an increased likelihood of requiring therapy (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) and requiring multiple lines of therapy (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.032). Non-obese patients who required corticosteroid treatment experienced a longer remission duration compared to obese patients (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.009) and were less likely to be steroid-dependent (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.048). Our findings suggest that obesity may be a significant risk factor for developing ITP and for ITP prognosis. Future studies are needed to evaluate the role of weight loss intervention in improving ITP outcomes.\n                  <\/jats:p>","DOI":"10.1007\/s00277-024-05836-3","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T06:02:07Z","timestamp":1718172127000},"page":"3453-3461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Obesity is associated with adverse outcomes in primary immune thrombocytopenia - a retrospective single-center study"],"prefix":"10.1007","volume":"103","author":[{"given":"Zhengrui","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hieu Liem Le","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul Kumar","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Bakri","family":"Hammami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Narvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charan Thej Reddy","family":"Vegivinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henny","family":"Billett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Murakhovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"issue":"3","key":"5836_CR1","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1182\/blood.V94.3.909.415k02_909_913","volume":"94","author":"H Frederiksen","year":"1999","unstructured":"Frederiksen H, Schmidt K (1999) The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 94(3):909\u2013913","journal-title":"Blood"},{"issue":"6","key":"5836_CR2","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1046\/j.1365-2141.2003.04547.x","volume":"122","author":"AJ Neylon","year":"2003","unstructured":"Neylon AJ, Saunders PW, Howard MR, Proctor SJ, Taylor PR, Northern Region Haematology G (2003) Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 122(6):966\u2013974. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04547.x","journal-title":"Br J Haematol"},{"issue":"11","key":"5836_CR3","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386\u20132393. https:\/\/doi.org\/10.1182\/blood-2008-07-162503","journal-title":"Blood"},{"issue":"4","key":"5836_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2141.2006.06024.x","volume":"133","author":"N Cooper","year":"2006","unstructured":"Cooper N, Bussel J (2006) The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol 133(4):364\u2013374. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06024.x","journal-title":"Br J Haematol"},{"issue":"5","key":"5836_CR5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/rth2.12388","volume":"4","author":"AZ Cheloff","year":"2020","unstructured":"Cheloff AZ, Kuter DJ, Al-Samkari H (2020) Serum complement levels in immune thrombocytopenia: characterization and relation to clinical features. Res Pract Thromb Haemost 4(5):807\u2013812. https:\/\/doi.org\/10.1002\/rth2.12388","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"5836_CR6","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1182\/blood-2007-12-129262","volume":"112","author":"R Stasi","year":"2008","unstructured":"Stasi R, Cooper N, Del Poeta G, Stipa E, Laura Evangelista M, Abruzzese E, Amadori S (2008) Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood 112(4):1147\u20131150. https:\/\/doi.org\/10.1182\/blood-2007-12-129262","journal-title":"Blood"},{"issue":"4","key":"5836_CR7","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1182\/blood-2003-08-2672","volume":"103","author":"R McMillan","year":"2004","unstructured":"McMillan R, Wang L, Tomer A, Nichol J, Pistillo J (2004) Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 103(4):1364\u20131369. https:\/\/doi.org\/10.1182\/blood-2003-08-2672","journal-title":"Blood"},{"issue":"3","key":"5836_CR8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1046\/j.1365-2141.1996.d01-1702.x","volume":"93","author":"S Kosugi","year":"1996","unstructured":"Kosugi S, Kurata Y, Tomiyama Y, Tahara T, Kato T, Tadokoro S, Shiraga M, Honda S, Kanakura Y, Matsuzawa Y (1996) Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. Br J Haematol 93(3):704\u2013706. https:\/\/doi.org\/10.1046\/j.1365-2141.1996.d01-1702.x","journal-title":"Br J Haematol"},{"issue":"2","key":"5836_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/bjh.18997","volume":"203","author":"X Zhang","year":"2023","unstructured":"Zhang X, Liu Q, Liu A, Leng S, Wang X, Zhao R, Sheng Z, Feng Q, Yang X, Wang S, Hou M, Peng J, Feng G (2023) Obesity is associated with poor outcomes of corticosteroid treatment in patients with primary immune thrombocytopenia. Br J Haematol 203(2):295\u2013303. https:\/\/doi.org\/10.1111\/bjh.18997","journal-title":"Br J Haematol"},{"issue":"9","key":"5836_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","volume":"13","author":"M Versini","year":"2014","unstructured":"Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y (2014) Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev 13(9):981\u20131000. https:\/\/doi.org\/10.1016\/j.autrev.2014.07.001","journal-title":"Autoimmun Rev"},{"issue":"1","key":"5836_CR11","first-page":"115","volume":"17","author":"E Hanafy","year":"2017","unstructured":"Hanafy E, Pakra MA (2017) Immune Thrombocytopenia and obesity: predictive relationship. Ochsner J 17(1):115\u2013117","journal-title":"Ochsner J"},{"issue":"2","key":"5836_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ajh.26036","volume":"96","author":"N Cooper","year":"2021","unstructured":"Cooper N, Kruse A, Kruse C, Watson S, Morgan M, Provan D, Ghanima W, Arnold DM, Tomiyama Y, Santoro C, Michel M, Laborde S, Lovrencic B, Hou M, Bailey T, Taylor-Stokes G, Haenig J, Bussel JB (2021) Immune Thrombocytopenia (ITP) World Impact Survey (I-WISh): impact of ITP on health-related quality of life. Am J Hematol 96(2):199\u2013207. https:\/\/doi.org\/10.1002\/ajh.26036","journal-title":"Am J Hematol"},{"issue":"2","key":"5836_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/13696998.2019.1669329","volume":"23","author":"D Weycker","year":"2020","unstructured":"Weycker D, Hanau A, Hatfield M, Wu H, Sharma A, Bensink ME, Chandler D, Grossman A, Tarantino M (2020) Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis. J Med Econ 23(2):184\u2013192. https:\/\/doi.org\/10.1080\/13696998.2019.1669329","journal-title":"J Med Econ"},{"key":"5836_CR14","unstructured":"Bronx (2021) Borough Health Equity Report"},{"issue":"4","key":"5836_CR15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3(4):692\u2013694. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x","journal-title":"J Thromb Haemost"},{"key":"5836_CR16","unstructured":"Prevention CfDCa (2022) Defining adult overweight & obesity. Centers for Disease Control and Prevention"},{"issue":"21","key":"5836_CR17","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","volume":"129","author":"MP Lambert","year":"2017","unstructured":"Lambert MP, Gernsheimer TB (2017) Clinical updates in adult immune thrombocytopenia. Blood 129(21):2829\u20132835. https:\/\/doi.org\/10.1182\/blood-2017-03-754119","journal-title":"Blood"},{"issue":"12","key":"5836_CR18","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/ajh.22170","volume":"86","author":"M Michel","year":"2011","unstructured":"Michel M, Rauzy OB, Thoraval FR, Languille L, Khellaf M, Bierling P, Godeau B (2011) Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study. Am J Hematol 86(12):980\u2013984. https:\/\/doi.org\/10.1002\/ajh.22170","journal-title":"Am J Hematol"},{"issue":"20","key":"5836_CR19","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1182\/blood.2021010968","volume":"137","author":"W Ghanima","year":"2021","unstructured":"Ghanima W, Gernsheimer T, Kuter DJ (2021) How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment. Blood 137(20):2736\u20132744. https:\/\/doi.org\/10.1182\/blood.2021010968","journal-title":"Blood"},{"issue":"1","key":"5836_CR20","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1080\/16078454.2021.2003066","volume":"26","author":"J Yu","year":"2021","unstructured":"Yu J, Xu Z, Zhuo Y, Wei H, Ye Y, Xu Q, Li Y, Yu L, Feng W, Hong P, Zhang K (2021) Development and validation of a nomogram for steroid-resistance prediction in immune thrombocytopenia patients. Hematology 26(1):956\u2013963. https:\/\/doi.org\/10.1080\/16078454.2021.2003066","journal-title":"Hematology"},{"issue":"1","key":"5836_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4274\/tjh.galenos.2021.2021.0183","volume":"39","author":"M Baysal","year":"2022","unstructured":"Baysal M, Bas V, Umit E, Kirkizlar HO, Demir AM (2022) Could antinuclear antibody positivity be a factor affecting treatment response in Immune Thrombocytopenia patients on Eltrombopag? Turk J Haematol 39(1):38\u201342. https:\/\/doi.org\/10.4274\/tjh.galenos.2021.2021.0183","journal-title":"Turk J Haematol"},{"issue":"11","key":"5836_CR22","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1007\/s00277-020-04257-2","volume":"99","author":"JC Jaime-Perez","year":"2020","unstructured":"Jaime-Perez JC, Aguilar-Calderon P, Jimenez-Castillo RA, Ramos-Davila EM, Salazar-Cavazos L, Gomez-Almaguer D (2020) Treatment outcomes and chronicity predictors for primary immune thrombocytopenia: 10-year data from an academic center. Ann Hematol 99(11):2513\u20132520. https:\/\/doi.org\/10.1007\/s00277-020-04257-2","journal-title":"Ann Hematol"},{"key":"5836_CR23","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.2147\/IJGM.S290459","volume":"13","author":"Y Sun","year":"2020","unstructured":"Sun Y, Long S, Liu W (2020) Risk factors and psychological analysis of Chronic Immune Thrombocytopenia in Children. Int J Gen Med 13:1675\u20131683. https:\/\/doi.org\/10.2147\/IJGM.S290459","journal-title":"Int J Gen Med"},{"issue":"23","key":"5836_CR24","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kuhne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK (2019) American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 3(23):3829\u20133866. https:\/\/doi.org\/10.1182\/bloodadvances.2019000966","journal-title":"Blood Adv"},{"issue":"2","key":"5836_CR25","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1017\/S0029665112000092","volume":"71","author":"FP de Heredia","year":"2012","unstructured":"de Heredia FP, Gomez-Martinez S, Marcos A (2012) Obesity, inflammation and the immune system. Proc Nutr Soc 71(2):332\u2013338. https:\/\/doi.org\/10.1017\/S0029665112000092","journal-title":"Proc Nutr Soc"},{"key":"5836_CR26","doi-asserted-by":"publisher","unstructured":"Balistreri CR, Caruso C, Candore G (2010) The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm 2010:802078. https:\/\/doi.org\/10.1155\/2010\/802078","DOI":"10.1155\/2010\/802078"},{"issue":"4","key":"5836_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.5114\/aoms.2016.58928","volume":"13","author":"MS Ellulu","year":"2017","unstructured":"Ellulu MS, Patimah I, Khaza\u2019ai H, Rahmat A, Abed Y (2017) Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci 13(4):851\u2013863. https:\/\/doi.org\/10.5114\/aoms.2016.58928","journal-title":"Arch Med Sci"},{"key":"5836_CR28","doi-asserted-by":"publisher","first-page":"594773","DOI":"10.3389\/fimmu.2021.594773","volume":"12","author":"AR Temming","year":"2021","unstructured":"Temming AR, Tammes Buirs M, Bentlage AEH, Treffers LW, Feringa H, de Taeye SW, Kuijpers TW, Nagelkerke SQ, Brasser G, Mok JY, van Esch WJE, van den Berg TK, Rispens T, van der Schoot CE, Vidarsson G (2021) C-Reactive protein enhances IgG-Mediated Cellular Destruction through IgG-Fc receptors in vitro. Front Immunol 12:594773. https:\/\/doi.org\/10.3389\/fimmu.2021.594773","journal-title":"Front Immunol"},{"key":"5836_CR29","doi-asserted-by":"publisher","first-page":"585887","DOI":"10.3389\/fendo.2021.585887","volume":"12","author":"M Obradovic","year":"2021","unstructured":"Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, Gojobori T, Isenovic ER (2021) Leptin and obesity: role and clinical implication. Front Endocrinol (Lausanne) 12:585887. https:\/\/doi.org\/10.3389\/fendo.2021.585887","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"5836_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1600-0609.2004.00231.x","volume":"72","author":"M Zhan","year":"2004","unstructured":"Zhan M, Zhao H, Yang R, Han ZC (2004) Serum leptin levels in patients with idiopathic thrombocytopenic purpura. Eur J Haematol 72(5):348\u2013352. https:\/\/doi.org\/10.1111\/j.1600-0609.2004.00231.x","journal-title":"Eur J Haematol"},{"issue":"2","key":"5836_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.clim.2006.04.573","volume":"120","author":"H Ren","year":"2006","unstructured":"Ren H, Zhao H, Wang T, Yang Y, Han Z, Liu B, Wu Z, Tao J, Zhou B, Zhang L, Yang R, Han ZC (2006) Leptin enhances in vitro secretion of IgG antiplatelet antibodies by splenocytes and peripheral blood mononuclear cells from patients with chronic idiopathic thrombocytopenic purpura. Clin Immunol 120(2):205\u2013211. https:\/\/doi.org\/10.1016\/j.clim.2006.04.573","journal-title":"Clin Immunol"},{"issue":"4911","key":"5836_CR32","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.2734615","volume":"244","author":"BS Rosen","year":"1989","unstructured":"Rosen BS, Cook KS, Yaglom J, Groves DL, Volanakis JE, Damm D, White T, Spiegelman BM (1989) Adipsin and complement factor D activity: an immune-related defect in obesity. Science 244(4911):1483\u20131487. https:\/\/doi.org\/10.1126\/science.2734615","journal-title":"Science"},{"issue":"2","key":"5836_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1600-0609.2011.01718.x","volume":"88","author":"A Najaoui","year":"2012","unstructured":"Najaoui A, Bakchoul T, Stoy J, Bein G, Rummel MJ, Santoso S, Sachs UJ (2012) Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP). Eur J Haematol 88(2):167\u2013174. https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01718.x","journal-title":"Eur J Haematol"},{"issue":"4","key":"5836_CR34","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1365-2141.2009.07995.x","volume":"148","author":"EI Peerschke","year":"2010","unstructured":"Peerschke EI, Andemariam B, Yin W, Bussel JB (2010) Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura. Br J Haematol 148(4):638\u2013645. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07995.x","journal-title":"Br J Haematol"},{"issue":"6","key":"5836_CR35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1182\/bloodadvances.2021006864","volume":"7","author":"CM Broome","year":"2023","unstructured":"Broome CM, Roth A, Kuter DJ, Scully M, Smith R, Wang J, Reuter C, Hobbs W, Daak A (2023) Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia. Blood Adv 7(6):987\u2013996. https:\/\/doi.org\/10.1182\/bloodadvances.2021006864","journal-title":"Blood Adv"},{"issue":"10","key":"5836_CR36","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1111\/jth.14970","volume":"18","author":"ML Stimpson","year":"2020","unstructured":"Stimpson ML, Lait PJP, Schewitz-Bowers LP, Williams EL, Thirlwall KF, Lee RWJ, Bradbury CA (2020) IL-10 and IL-17 expression by CD4(+) T cells is altered in corticosteroid refractory immune thrombocytopenia (ITP). J Thromb Haemost 18(10):2712\u20132720. https:\/\/doi.org\/10.1111\/jth.14970","journal-title":"J Thromb Haemost"},{"key":"5836_CR37","doi-asserted-by":"publisher","unstructured":"Chehimi M, Vidal H, Eljaafari A (2017) Pathogenic role of IL-17-Producing Immune cells in obesity, and related inflammatory diseases. J Clin Med 6(7). https:\/\/doi.org\/10.3390\/jcm6070068","DOI":"10.3390\/jcm6070068"},{"issue":"3","key":"5836_CR38","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1210\/jc.2002-021437","volume":"88","author":"K Esposito","year":"2003","unstructured":"Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, Nicoletti G, Giugliano D (2003) Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 88(3):1055\u20131058. https:\/\/doi.org\/10.1210\/jc.2002-021437","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5836_CR39","doi-asserted-by":"publisher","first-page":"e8094","DOI":"10.7759\/cureus.8094","volume":"12","author":"F Angum","year":"2020","unstructured":"Angum F, Khan T, Kaler J, Siddiqui L, Hussain A (2020) The prevalence of Autoimmune disorders in women: a narrative review. Cureus 12(5):e8094. https:\/\/doi.org\/10.7759\/cureus.8094","journal-title":"Cureus"},{"issue":"9","key":"5836_CR40","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3324\/haematol.2016.146373","volume":"101","author":"L Grimaldi-Bensouda","year":"2016","unstructured":"Grimaldi-Bensouda L, Nordon C, Michel M, Viallard JF, Adoue D, Magy-Bertrand N, Durand JM, Quittet P, Fain O, Bonnotte B, Morin AS, Morel N, Costedoat-Chalumeau N, Pan-Petesch B, Khellaf M, Perlat A, Sacre K, Lefrere F, Abenhaim L, Godeau B, Group for the P-ITPS (2016) Immune Thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome. Haematologica 101(9):1039\u20131045. https:\/\/doi.org\/10.3324\/haematol.2016.146373","journal-title":"Haematologica"},{"issue":"2","key":"5836_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1600-0609.2009.01247.x","volume":"83","author":"PE Abrahamson","year":"2009","unstructured":"Abrahamson PE, Hall SA, Feudjo-Tepie M, Mitrani-Gold FS, Logie J (2009) The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review. Eur J Haematol 83(2):83\u201389. https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01247.x","journal-title":"Eur J Haematol"},{"issue":"22","key":"5836_CR42","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1182\/blood-2014-05-578336","volume":"124","author":"G Moulis","year":"2014","unstructured":"Moulis G, Palmaro A, Montastruc JL, Godeau B, Lapeyre-Mestre M, Sailler L (2014) Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood 124(22):3308\u20133315. https:\/\/doi.org\/10.1182\/blood-2014-05-578336","journal-title":"Blood"},{"issue":"3","key":"5836_CR43","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/eva.13167","volume":"14","author":"VL Kronzer","year":"2021","unstructured":"Kronzer VL, Bridges SL Jr., Davis JM 3rd (2021) Why women have more autoimmune diseases than men: an evolutionary perspective. Evol Appl 14(3):629\u2013633. https:\/\/doi.org\/10.1111\/eva.13167","journal-title":"Evol Appl"},{"issue":"12","key":"5836_CR44","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3324\/haematol.2011.050799","volume":"96","author":"T Kuhne","year":"2011","unstructured":"Kuhne T, Berchtold W, Michaels LA, Wu R, Donato H, Espina B, Tamary H, Rodeghiero F, Chitlur M, Rischewski J, Imbach P, Intercontinental Cooperative ITPSG (2011) Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group. Haematologica 96(12):1831\u20131837. https:\/\/doi.org\/10.3324\/haematol.2011.050799","journal-title":"Haematologica"},{"key":"5836_CR45","unstructured":"Bronx Community Health Dashboard: Nutrition Physical Activity and Obesity (2018) https:\/\/www.montefiore.org\/documents\/communityservices\/OCPH-Dashboard-Obesity.pdf"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05836-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05836-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05836-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T05:13:31Z","timestamp":1724822011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05836-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["5836"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05836-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4133780\/v1","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"assertion":[{"value":"20 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}